Online citations, reference lists, and bibliographies.

Reactions With Antisera And Pathological Effects Of Staphylococcus Aureus Gamma-Toxin In The Cornea

Michael A Bierdeman, A. Merino Torres, Armando Caballero, Aihua Tang, Richard J O'Callaghan
Published 2017 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
ABSTRACT Purpose: This study analyzed the toxicity of purified gamma-toxin from Staphylococcus aureus and the protectiveness of antisera to gamma-toxin in the rabbit cornea. Materials and methods: Gamma-toxin was purified from cultures of alpha-toxin deficient S. aureus strain Newman Δhla. Antisera to native gamma-toxin (Hlg) were produced in rabbits. These antisera and a commercial polyclonal antibody to recombinant HlgB (rHlgB) were analyzed for specificity and toxin neutralization. Heat-inactivated gamma-toxin, active gamma-toxin either alone or with antisera or with commercial antibody to rHlgB, was injected into the rabbit cornea to observe the pathological effects using slit lamp examination scoring (SLE) and histological analyses. Results: Eyes with intrastromal injection of gamma-toxin developed SLE scores that were significantly higher than eyes injected with heat-inactivated gamma-toxin (p ≤ 0.003). Slit lamp and histological examination of eyes revealed that gamma-toxin injected into the cornea mediated conjunctival injection and chemosis, iritis, fibrin accumulation in the anterior chamber, and polymorphonuclear neutrophil infiltration of the cornea and iris. Also, eyes injected with gamma-toxin plus antisera to native whole gamma-toxin or HlgB, but not with commercial antibody to rHlgB, yielded significantly lower SLE scores than eyes injected with gamma-toxin alone (p ≤ 0.003). Conclusions: This study illustrates that S. aureus gamma-toxin is capable of causing significant corneal pathology. Furthermore, the use of polyclonal antisera specific for native gamma-toxin was found to inhibit the damaging effects of the toxin in the rabbit cornea.
This paper references
10.1111/j.1600-065X.2008.00681.x
The bacterial superantigen and superantigen-like proteins.
J. Fraser (2008)
10.1016/S1542-0124(12)70620-1
Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.
M. Lemp (2009)
10.1128/CMR.15.1.111-124.2002
Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions
M. Callegan (2002)
10.1016/S0076-6879(88)65005-1
Preparation and purification of gamma-hemolysin of staphylococci.
M. Plommet (1988)
10.1110/PS.4360102
Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore.
G. Miles (2002)
10.1128/IAI.68.10.6052-6055.2000
Immunization with Alpha-Toxin Toxoid Protects the Cornea against Tissue Damage during Experimental Staphylococcus aureus Keratitis
E. B. Hume (2000)
10.1016/j.ajo.2013.01.027
Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases.
A. M. Schimel (2013)
10.1016/j.ijmm.2009.10.003
Interaction of staphylococci with bone
J. A. Wright (2010)
10.1076/CEYR.16.12.1221.5022
Histopathological studies of staphylococcal alpha-toxin: effects on rabbit corneas.
J. M. Moreau (1997)
10.1128/iai.61.9.3879-3885.1993
The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.
A. Abdelnour (1993)
10.1167/IOVS.04-0897
Effects of toxin production in a murine model of Staphylococcus aureus keratitis.
D. Girgis (2005)
10.1136/bjo.68.8.524
Comparative bacteriology of chronic blepharitis.
J. Dougherty (1984)
10.1097/00003226-199909000-00003
Conjunctival impression cytology and tear-film changes in patients with psoriasis.
A. Karabulut (1999)
Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
R. O'Callaghan (1996)
Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis.
M. Booth (1995)
10.3109/09273948.2014.920035
Effectiveness of Alpha-toxin Fab Monoclonal Antibody Therapy in Limiting the Pathology of Staphylococcus aureus Keratitis
Armando Caballero (2015)
10.1128/IAI.67.7.3348-3356.1999
Pathogenesis of Gram-Positive Bacterial Endophthalmitis
M. Callegan (1999)
10.1167/iovs.13-12130
Recurrent bacterial keratitis.
Rebecca Kaye (2013)
10.1016/J.OPHTHA.2007.03.076
Update on bacterial conjunctivitis in South Florida.
Kara M Cavuoto (2008)
10.1016/j.bbamem.2008.01.026
Pore formation: an ancient yet complex form of attack.
I. Iacovache (2008)
10.1016/j.ajo.2013.09.007
Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases.
G. Carifi (2013)
10.1016/S0161-6420(00)00179-2
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
G. Alexandrakis (2000)
10.1042/BJ20051878
Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.
O. Joubert (2006)
Staphylococcal accessory regulator (sar) in CURRENT EYE RESEARCH 7 conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis
MC Booth (1997)
10.1111/j.1444-0938.2010.00536.x
Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins
M. Willcox (2011)
Staphylococcal accessory regulator (sar) in 1106 M. A. BIERDEMAN ET AL. conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis
MC Booth (1997)
10.1001/archophthalmol.2010.144
Epidemiology of ulcerative keratitis in Northern California.
B. Jeng (2010)
10.1073/pnas.1102265108
Heavy chain-only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins
Benoît-Joseph Laventie (2011)
Role of exoproteins in bacterial keratitis: the Fourth Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, November 7, 1998.
R. O'Callaghan (1999)
10.1016/0923-2508(91)90099-V
Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains.
V. Finck-Barbançon (1991)
10.1089/10445490260099656
Corneal virulence of Staphylococcus aureus in an experimental model of keratitis.
J. Dajcs (2002)
10.1086/520289
Staphylococcus aureus: a well-armed pathogen.
G. Archer (1998)
10.1128/JB.00043-08
Staphylococcus aureus--probing for host weakness?
I. L. Camargo (2008)
10.1016/S0039-6257(03)00054-7
Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.
T. Jackson (2003)
10.1128/iai.65.5.1571-1578.1997
Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection.
R. O'Callaghan (1997)
10.1073/pnas.1110402108
Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components
K. Yamashita (2011)
10.1385/1-59259-026-8:79
Infective endocarditis.
M. Terpenning (1992)
10.1128/iai.65.4.1550-1556.1997
Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis.
M. Booth (1997)
10.1086/320184
Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999.
D. Diekema (2001)
10.1016/j.vaccine.2012.05.067
Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
A. R. Spaulding (2012)
Corneal pathogenesis of Staphylococcus aureus strain Newman.
J. Dajcs (2002)
10.1016/S0966-842X(98)01400-0
Surface protein adhesins of Staphylococcus aureus.
T. Foster (1998)
10.1016/J.AJO.2003.11.013
Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.
Vivian Schiedler (2004)
10.1099/00222615-46-6-486
Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model.
J. A. Siqueira (1997)
10.1167/iovs.13-11701
Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology.
T. Zaidi (2013)
10.1128/IAI.67.3.1045-1049.1999
Alpha-Toxin and Gamma-Toxin Jointly PromoteStaphylococcus aureus Virulence in Murine Septic Arthritis
I. M. Nilsson (1999)
10.1016/S0014-5793(98)01130-2
Characterization of a novel structural member, LukE‐LukD, of the bi‐component staphylococcal leucotoxins family
A. Gravet (1998)
10.1128/IAI.73.6.3806-3809.2005
A rot Mutation Restores Parental Virulence to an agr-Null Staphylococcus aureus Strain in a Rabbit Model of Endocarditis
P. McNamara (2005)
10.1016/j.meegid.2013.03.013
Staphylococcus aureus toxins--their functions and genetics.
D. Grumann (2014)
10.1371/journal.pone.0060033
Infective Endocarditis in the U.S., 1998–2009: A Nationwide Study
D. Bor (2013)
10.1006/MPAT.1997.0192
Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus.
G. Supersac (1998)
10.1111/cmi.12130
Staphylococcal alpha‐phenol soluble modulins contribute to neutrophil lysis after phagocytosis
B. G. J. Surewaard (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar